Meiri D

ORCID: 0000-0001-7627-1569 · 2 papers in corpus
other 2023
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph16101426

BACKGROUND: Clinical studies on medical cannabis (MC) treatment have shown sex-related differences, including higher susceptibility to adverse events among women and greater analgesia among men. Here, we used the Syqe metered-dose inhaler (…

observational 2020
Rambam Maimonides medical journal ·doi:10.5041/rmmj.10384

OBJECTIVE: The aim of this cross-sectional questionnaire-based study was to identify associations between the doses of cannabinoids and terpenes administered, and symptoms of attention deficit hyperactivity disorder (ADHD). METHODS: Partic…